EX-99.1 2 ea179923ex99-1_incannex.htm ASX ANNOUNCEMENT, DATED JUNE 6, 2023 - CHANGE OF DIRECTOR'S INTEREST NOTICE

Exhibit 99.1

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 Rule 3.19A.2

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

 

Introduced 30/09/01 Amended 01/01/11

 

Name of entity INCANNEX HEALTHCARE LIMTIED
ABN 93 096 635 246

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director Joel Latham
Date of last notice 12 August 2022

 

Part 1 - Change of director’s relevant interests in securities

 

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest

 

 Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

  
Date of change 2 June 2023
No. and class of securities held prior to change

●      18,097,541 IHL ordinary shares

●      2,850,872 IHL ordinary shares escrowed until 30.06.2023

●      1,866,667 IHL ordinary shares escrowed until 30.06.2024

●      933,334 IHL ordinary shares escrowed until 30.06.2025

 

●      1,500,000 unlisted $0.05 options expiring 30.06.2025

●      750,000 unlisted $0.05 options expiring 30.06.2026

●      750,000 unlisted $0.05 options expiring 30.06.2026 (ESC)

●      1,500,000 unlisted $0.05 options expiring 30.06.2027 (ESC)

●      1,866,666 unlisted $0.26 options expiring 01.05.2025

●      1,866,666 unlisted $0.31 options – vesting 30.06.2023 and expiring 01.05.2026

●      1,866,668 unlisted $0.35 options– vesting 30.06.2024 and expiring 01.05.2027

 

Number acquired

 

 1,583,227 unlisted $0.25 options expiring on 30 April 2026

 

 

+See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 1

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Number disposed Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

 $1,583.23
No. of securities held after change

●      18,097,541 IHL ordinary shares

●      2,850,872 IHL ordinary shares escrowed until 30.06.2023

●      1,866,667 IHL ordinary shares escrowed until 30.06.2024

●      933,334 IHL ordinary shares escrowed until 30.06.2025

 

●      1,500,000 unlisted $0.05 options expiring 30.06.2025

●      750,000 unlisted $0.05 options expiring 30.06.2026

●      750,000 unlisted $0.05 options expiring 30.06.2026 (ESC)

●      1,500,000 unlisted $0.05 options expiring 30.06.2027 (ESC)

●      1,866,666 unlisted $0.26 options expiring 01.05.2025

●      1,866,666 unlisted $0.31 options – vesting 30.06.2023 and expiring 01.05.2026

●      1,866,668 unlisted $0.35 options– vesting 30.06.2024 and expiring 01.05.2027

●      1,583,227 unlisted $0.25 options expiring on 30 April 2026

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 

 Purchase of Loyalty Options

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract

 

 N/A

Nature of interest

 

  

Name of registered holder

(if issued securities)

 

  

Date of change

 

  

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

  

Interest acquired

 

  

Interest disposed

 

  

 

 

+See chapter 19 for defined terms.

 

Appendix 3Y Page 2 01/01/2011

 

 

 

Appendix 3Y
Change of Director’s Interest Notice

 

 

  

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

  

Interest after change

 

  

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No.
If so, was prior written clearance provided to allow the trade to proceed during this period?  
If prior written clearance was provided, on what date was this provided?  

 

 

+See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 3

 

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

 

Introduced 30/09/01 Amended 01/01/11

 

Name of entity INCANNEX HEALTHCARE LIMTIED
ABN 93 096 635 246

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director Peter Widdows  
Date of last notice 21 September 2021

 

Part 1 - Change of director’s relevant interests in securities

 

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest Direct and indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

 The Peter Widdows Superannuation Fund (Benficiary)
Date of change 2 June 2023
No. and class of securities held prior to change

DIRECT

●    15,973,685 IHL ordinary shares

 

INDIRECT

●    600,0000 IHL ordinary shares

 

Number acquired

DIRECT

●    1,064,913 unlisted $0.25 options expiring on 30 April 2026

 

INDIRECT

●    40,000 unlisted $0.25 options expiring on 30 April 2026

Number disposed Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

 $1,104.92

 

 

+See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 1

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

No. of securities held after change

DIRECT

●    15,973,685 IHL ordinary shares

●    1,064,913 unlisted $0.25 options expiring on 30 April 2026

 

INDIRECT

●    600,0000 IHL ordinary shares

●    40,000 unlisted $0.25 options expiring on 30 April 2026

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 Purchase of Loyalty Options

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract N/A

Nature of interest

 

 

  

Name of registered holder

(if issued securities)

 

  
Date of change  

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

  
Interest acquired  
Interest disposed  

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

  
Interest after change  

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No.
If so, was prior written clearance provided to allow the trade to proceed during this period?  
If prior written clearance was provided, on what date was this provided?  

 

 

+See chapter 19 for defined terms.

 

Appendix 3Y Page 2 01/01/2011

 

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

 

Introduced 30/09/01 Amended 01/01/11

 

Name of entity    INCANNEX HEALTHCARE LIMTIED
ABN           93 096 635 246

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director Troy Valentine  
Date of last notice 12 August 2022

 

Part 1 - Change of director’s relevant interests in securities

 

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest Direct and indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

 See notes below
Date of change 2 June 2023
No. and class of securities held prior to change

●       36, 651 198 IHL Ordinary Shares

●      2,800,000 Options with various exercise prices, vesting dates and expiry dates.

 

Number acquired ●      2,443,413 unlisted $0.25 options expiring on 30 April 2026
Number disposed Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

 $2,443.41
No. of securities held after change

●     36, 651 198 IHL Ordinary Shares

●     2,800,000 Options with various exercise prices, vesting dates and expiry dates.

●     2,443,413 unlisted $0.25 options expiring on 30 April 2026

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 Purchase of Loyalty Options

 

 

+See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 1

 

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract N/A
Nature of interest  

Name of registered holder

(if issued securities)

 

  
Date of change  

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

  
Interest acquired  
Interest disposed  

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

  
Interest after change  

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No.
If so, was prior written clearance provided to allow the trade to proceed during this period?  
If prior written clearance was provided, on what date was this provided?  

 

 

+See chapter 19 for defined terms.

 

Appendix 3Y Page 2 01/01/2011

 

 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

Notes – Direct & Indirect Interests

(a) Description of entities/relationships:

 

1.Troy Valentine is:
   
a.A beneficiary of the GFCR Investments Trust, the FT Family Trust, and the Troy R Valentine Superfund;
   
b.A director of Tranaj Nominees Pty Ltd, Valplan Pty Ltd, Alignment Capital Pty Ltd and Cityside Pty Ltd
   
c.100% shareholder in Cityside Pty Ltd (ACN 112 375 354)(“Cityside”)
   
d.50% shareholder in Alignment Capital Pty Ltd (ACN 167 124 754)(“Alignment”)

 

2.Ekirtson Nominees Pty Ltd (ACN 137 521 825) is trustee for the GFCR Investments Trust (“Ekirtson”)

 

3.Tranaj Nominees Pty Ltd (ACN 137 521 843) is trustee of the FT Family Trust (“Tranaj”)

 

4.Valplan Pty Ltd (ACCN 135 269 169) is trustee of the Troy R Valentine Family Superfund (“Valplan”)

 

(b) Table 1 – holdings before changes

 

   IHL Ordinary
Shares		   IHL Options 
Troy Valentine   2,925,000^    2,800,000^^ 
Ekirtson *   2,875,000      
Tranaj *   10,216,950      
Valplan   3,000,000      
Alignment *   13,194,248      
Cityside   4,440,000      
TOTAL   36,651,198      

 

(c) Table 2 – holdings after changes

 

  IHL Ordinary
Shares		   IHL Options 
Troy Valentine   2,925,000^    2,994,999^^ 
Ekirtson *   2,875,000    191,667 
Tranaj *   10,216,950    681,130 
Valplan   3,000,000    200,000 
Alignment *   13,194,248    879,617 
Cityside   4,440,000    296,000 
TOTAL   36,651,198    5,243,413 

 

*Mr Valentine is not the sole beneficiary of these entities.
^Of these 2,333,334 Securities issued to KMP as part of remuneration package for FY 21 and 22, subsequent to Shareholder Approval obtained at the General Meeting of the Company on 09 June 2022; with vesting dates as per details in the Notice of Meeting dated 12 May 2022. 466,666 Shares have already vested.
^^Securities issued to KMP as part of remuneration package for FY 21 and 22, subsequent to Shareholder Approval obtained at the General Meeting of the Company on 09 June 2022; with vesting dates as per details in the Notice of Meeting dated 12 May 2022.

 

 

+See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 3